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ABSTRACT
Background: Reducing risk factors, such as exposure to allergens, and stepwise pharmacotherapy to
achieve and maintain control of asthma are the mainstay of asthma care. The purpose of this study was to clar-
ify the effect of exposure and sensitization to indoor allergens, including house dust mites, cats, and dogs, on
the asthma control level.
Methods: Dust samples were collected from the mattresses of 101 adult asthma patient homes and the Der-
matophagoides mite group 1 (Der 1), Fel d 1, and Can f 1 concentrations were measured using ELISA. Sensiti-
zation was determined by positive specific IgE antibodies. The Asthma Control Test (ACT), lowest peak expira-
tory flow (PEF) during 1 week expressed as a percentage of the highest PEF (Min%Max PEF), and spirometry
were measured for the assessment of asthma control. Univariate and multivariate regression analyses were
used to assess the relationships.
Results: Sixty-nine patients were exposed to high levels (>10 μgg dust for Der 1 and Can f 1 and >8 μgg
dust for Fel d 1) of 1 or more allergens and 39 patients were sensitized to at least one allergen. Multivariate lo-
gistic regression analyses revealed that the FEV1 (% of predicted value) was associated with low ACT scores
(19) and that the number of highly exposed allergens and inhaled corticosteroid dose were associated with a
low level of Min%Max PEF (<80%).
Conclusions: The level of exposure to multiple indoor allergens, but not sensitization, is associated with the
asthma control level determined by PEF variation.
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ABBREVIATIONS
ACT, Asthma Control Test; Der 1, Dermatophagoides mite group 1; FVC, forced vital capacity; Min%Max PEF,
lowest peak expiratory flow during 1 week expressed as a percentage of the highest peak expiratory flow; PEF,
peak expiratory flow.
INTRODUCTION
The mainstay of asthma care includes reducing risk
factors and a stepwise approach to pharmacologic
treatment to achieve and maintain control of asthma.1
Exposure and sensitization to indoor allergens, in-
cluding house dust mites, cats, and dogs, are impor-
tant risk factors for asthma. Indoor allergen exposure
in the development of allergic sensitization and
asthma remains controversial; however, studies have
shown that indoor allergens play a key role in trigger-
ing and exacerbating asthma symptoms.2-6
There are some differences in the role of exposure
and sensitization in asthma. Several investigators
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have reported that sensitization and exposure to cat
allergens were associated with asthma but not dust
mite allergens,2,3 while others found a relationship
between multiple indoor allergen exposure and
asthma symptoms.4-6 Lack of an association between
allergen sensitization and asthma morbidity has also
been reported.7 Further, most studies focused mainly
on asthma severity and only a few studies referred to
asthma control levels.
The purpose of this study was to clarify the effect
of exposure and sensitization to indoor allergens on
the asthma control level in clinical practice. We meas-
ured the concentrations of dust mite, cat, and dog al-
lergens in dust samples on bedding and specific IgE
antibody positivity, and examined the relationships
with asthma control variables, including the Asthma
Control Test (ACT) and the lowest PEF during 1
week, expressed as a percentage of the highest PEF
(Min%Max PEF) in adult patients with asthma.
METHODS
SUBJECTS
One hundred one patients with asthma who attended
outpatient clinics at Shizuoka General Hospital for
routine check-ups between April 2008 and March
2009 were enrolled in this study. These patients were
selected without prejudice by a coauthor (T. S.) who
had not seen them or their medical records previ-
ously. All patients satisfied the definition of asthma of
GINA 2006,1 and were treated based on their asthma
control level; that is, the patient’s current level of
asthma control and current treatment determined the
selection of pharmacologic treatment. If asthma was
not controlled using the current treatment regimen,
treatment was stepped up until control was achieved.
If control had been maintained for at least 3 months,
treatment could be stepped down. Atopy was defined
by positive specific IgE antibodies to at least one com-
mon inhalant allergen (CAP system; Pharmacia,
Uppsala, Sweden). Inclusion criteria were as follows:
(1) age between 20 and 80 years; (2) ability to per-
form an adequate forced expiratory maneuver; and
(3) receiving inhaled corticosteroids with or without
other medications for asthma, including long-acting
β2-agonists, leukotriene receptor antagonists, or sus-
tained release theophylline for at least 3 months. Pa-
tients were excluded from the study if they (1) had
had any acute viral infections within at least 1 month
before the study; (2) had a smoking history of >10
pack-years; (3) had chronic obstructive pulmonary
disease; (4) had cardiovascular diseases; or (5) were
pregnant. Peak expiratory flow (PEF) monitoring was
performed in 81 patients using a Miniwright peak
flow meter (Clement Clarke International Ltd., Har-
low, UK). The protocols were approved by the local
ethics committee and informed consent was obtained
from all patients prior to the study.
EXPOSURE AND SENSITIZATION TO INDOOR
ALLERGENS
Dust samples were collected for 2 min from a 1 m2
area of the mattress using a hand-held vacuum
cleaner (HC-V15; Panasonic, Osaka, Japan).8 All sam-
ples were assayed for the Dermatophagoides mite
group 1 (Der 1), Fel d 1, and Can f 1 content using
ELISA, as previously described.9 The results were ex-
pressed as micrograms of allergen per gram of dust
(μgg dust). Subjects were classified as being ex-
posed to high levels of domestic allergens if the con-
centration was >10 μgg dust for Der 1 and Can f 1
and >8 μgg dust for Fel d 1, respectively.4,6 The ex-
posure score was defined as the number of highly ex-
posed allergens ranging from 0 to 3.
Sensitization to dust mites, cats, and dogs was de-
termined by positive specific IgE antibodies (CAP
system; Pharmacia). Specific IgE titers 0.7 UAml
were considered positive and the sensitization score
was defined as the number of positive allergens rang-
ing from 0 to 3.
STUDY DESIGN
On the examination day within 1 week from dust
sampling, the patients completed the ACT question-
naire and underwent testing by spirometry. The ACT
(Japanese version, supplied by GlaxoSmithKline Ja-
pan) questionnaire consists of 5 items assessing the
impact of asthma on everyday functioning at school
or work, shortness of breath, nocturnal asthma symp-
toms, use of rescue medication, and the patient’s self-
rating of asthma control during the previous 4
weeks.10,11 Spirometry was determined using comput-
erized equipment (model CHESTAC-33; CHEST MI,
Inc., Tokyo, Japan). FEV1 was expressed as a per-
centage of predicted values according to the formula
of the Japanese Respiratory Society,12 and FEV1
forced vital capacity (FVC) was also calculated. In pa-
tients who recorded their PEF values at home, the
Min%Max PEF values13 during the 2-week period
prior to examination were calculated.
STATISTICAL ANALYSIS
Categorical data are summarized as counts, and
quantitative data are summarized as medians with
ranges. The patients were classified into controlled or
less controlled groups according to the following cut-
off values: 20 versus 19 in ACT scores and 80%
versus <80% in Min%Max PEF. Concerning PEF
monitoring, no difference was found in quantitative
and categorical data between the 81 patients with
complete data and the remaining 20 patients with in-
complete data by the t-test and chi-square test, re-
spectively. Logistic regression analyses were per-
formed to assess the relationships between exposure
and sensitization and asthma control variables. After
initial univariate analyses, variables that had p < 0.05
in the univariate models were included in the multi-
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Table　1　Characteristics of the study patients
Characteristics Findings (n = 101)
Age, median (range), y 60 (22-77)
Male/female, No. 46/55
Non/ex/current smokers, No. 51/36/14
Atopic/non-atopic, No. 72/29
Current pet owners (cat/dog), No. 32 (14/19)
Coexisting nasal diseases, No. 55
Duration of asthma, median (range), y 10 (1-51)
FEV1, median (range), % of predicted 
value
87.0 (29.6-145.7)
FEV1/FVC, median (range), % 72.3 (25.2-100.0)
Allergen level, median (range), μg/g dust
Der 1 14.9 (0.44-108.00)
Fel d 1 0.13 (0.00-5594.00)
Can f 1 0.36 (0.13-997.00)
Exposure to high levels of allergens†
Dust mite/cat/dog, No. 57/15/13
Exposure scores 0/1/2/3, No. 32/54/15/0
Specifi c IgE titers, median (range), UA/ml
Dust mite 0.34 (0.34-100.00)
Cat 0.34 (0.34-100.00)
Dog 0.34 (0.34-87.30)
Allergen sensitization (positive test results)‡
Dust mite/cat/dog, No. 34/17/16
Sensitization scores 0/1/2/3 62/21/8/10
ACT scores, median (range) 24 (6-25)
≥20, No.  85
≤19, No.  16
Min%Max PEF, median (range)§ 88.9 (60.0-100.0)
≥80, No.  67
<80, No.  14
Total IgE, median (range), U/ml 135.5 (8.4-12550.6)
Inhaled corticosteroids, No. 101
dose, median (range), μg/day¶ 400 (200-1000)
Long-acting β2-agonists, No.  52
Leukotriene receptor antagonists, No.  50
Sustained-release theophylline, No.  40
Prednisolone, No.   7
No. of medications, median (range) 2 (1-6)
Abbreviations: ACT, asthma control test; Der 1, Dermatophagoi-
des mite group 1; FEV1, forced expiratory volume in 1 s; FVC, 
forced vital capacity; Min%Max PEF, lowest peak expiratory fl ow 
during 1 week expressed as a percentage of the highest peak ex-
piratory fl ow; PEF, peak expiratory fl ow.
†High level of exposure means >10 μg/g dust for Der 1 and Can 
f 1 and >8 μg/g dust for Fel d 1, respectively. Exposure score was 
defi ned as the number of highly exposed allergens ranging from 0 
to 3.
‡Specifi c IgE levels ≥0.7 UA/ml were considered positive. Sen-
sitization score was defi ned as the number of positive allergens 
ranging from 0 to 3.
§PEF monitoring was performed in 81 patients.
¶Fluticasone propionate or equivalent.
Fig.　1　Concentrations of Der 1, Fel d 1, and Can f 1 aller-
gens in dust samples collected from bedding from 101 pa-
tient homes. Horizontal bars represent medians.
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variate models together with variables concerning ex-
posure and sensitization. Otherwise, variables
deemed of clinical significance regardless of statisti-
cal significance were included in the model. Stat View
Version 5.0 (SAS Institute, Cary, NC, USA) was used
for statistical calculations. A p value of <0.05 was con-
sidered significant, and all tests were 2 sided.
RESULTS
The clinical characteristics of the study population
are shown in Table 1. Der 1, Fel d 1, and Can f 1 lev-
els in the samples from bedding surfaces are pre-
sented in Figure 1. It was found that the median Der
1 level was higher than 10 μgg dust, that 69 patients
were exposed to high levels of at least one domestic
allergen, and 39 patients were sensitized to at least
one allergen. There were 32 current pet owners.
Eleven non-cat owners and 11 non-dog owners were
sensitized to cats and dogs, respectively, while 9 cat
owners and 13 dog owners were not sensitized to cats
and dogs, respectively.
In the univariate models (Table 2), the FEV1 and
inhaled corticosteroid dose were associated with low
ACT scores, but no other factor was associated, in-
cluding allergen concentrations, allergen-specific IgE
titers, and exposure and sensitization scores. Unlike
ACT scores, no factor was associated with low levels
of Min%Max PEF (Table 3).
Multivariate logistic regression analysis was per-
formed by including the duration of asthma, FEV1, in-
haled corticosteroid dose, and variables concerning
exposure and sensitization. As shown in Table 4, the
FEV1 was negatively associated with low ACT scores,
whereas exposure scores and the inhaled corticoster-
oid dose were positively associated, but did not reach
statistical significance (Table 4). The results from the
Shirai T et al.
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Table　2　Univariate analysis for factors associated with low 
ACT scores (≤19)
Characteristics OR 95% CI p Value
Age 0.990 0.956-1.026 0.598
Female sex 1.090 0.372-3.197 0.875
Current smoking 1.364 0.290-6.416 0.695
Atopy 1.155 0.363-3.678 0.807
Current pet owners 1.253 0.378-4.156 0.713
Absence of nasal diseases 0.917 0.313-2.691 0.875
Duration of asthma (×10), y 0.914 0.554-1.508 0.725
FEV1, % of predicted value 0.961 0.936-0.988 0.004
FEV1/FVC, % 0.974 0.938-1.013 0.185
Der 1, μg/g dust 1.001 0.979-1.023 0.926
Fel d 1, μg/g dust 1.000 0.998-1.001 0.786
Can f 1, μg/g dust 1.000 0.996-1.003 0.779
Exposure scores 1.124 0.503-2.515 0.775
Dust mite-specifi c IgE titers, 
UA/ml
1.001 0.980-1.023 0.909
Cat-specifi c IgE titers, UA/ml 0.978 0.890-1.076 0.648
Dog-specifi c IgE titers, UA/ml 0.974 0.842-1.127 0.724
Sensitization scores 0.865 0.484-1.548 0.625
Log (Total IgE), U/ml 1.061 0.444-2.539 0.894
Inhaled corticosteroids, dose 
(×100), μg/day†
1.248 1.032-1.510 0.022
Abbreviations: CI, confi dence interval, Der 1.
†Fluticasone propionate or equivalent.
Table　3　Univariate analysis for factors associated with low 
levels of Min%Max PEF (<80%)
Characteristics OR 95% CI p Value
Age 1.005 0.962-1.050 0.806
Female sex 1.219 0.381-3.897 0.738
Current smoking 0.550 0.055-5.457 0.610
Atopy 1.404 0.416-4.733 0.585
Current pet owners 0.822 0.245-2.753 0.750
Absence of nasal diseases 1.393 0.439-4.420 0.574
Duration of asthma (×10), y 0.894 0.522-1.534 0.685
FEV1, % of predicted value 0.980 0.955-1.006 0.128
FEV1/FVC, % 0.976 0.936-1.018 0.185
Der 1, μg/g dust 0.991 0.962-1.021 0.559
Fel d 1, μg/g dust 0.997 0.985-1.009 0.620
Can f 1, μg/g dust 1.002 0.999-1.004 0.180
Exposure scores 1.335 0.580-3.070 0.497
Dust mite-specifi c IgE titers, 
UA/ml
0.984 0.948-1.021 0.383
Cat-specifi c IgE titers, UA/ml 0.763 0.337-1.726 0.516
Dog-specifi c IgE titers, UA/ml 0.092 0.054-28.883 0.416
Sensitization scores 0.555 0.236-1.305 0.177
Log (Total IgE), U/ml 0.914 0.355-2.351 0.852
Inhaled corticosteroids, dose 
(×100), μg/day†
1.191 0.962-1.476 0.109
Abbreviations: CI, confi dence interval.
†Fluticasone propionate or equivalent.
Table　4　Multivariate analysis for factors associated with 
low ACT scores (≤19)
Characteristics AdjustedOR 95% CI p Value
Duration of asthma (×10), y 0.760 0.381-1.514 0.435
FEV1, % of predicted value 0.960 0.926-0.996 0.028
Der 1, μg/g dust 0.979 0.939-1.020 0.315
Fel d 1, μg/g dust 0.998 0.992-1.004 0.573
Can f 1, μg/g dust 0.709 0.417-1.205 0.204
Exposure scores 3.984 0.806-19.687 0.090
Dust mite-specifi c IgE titers, 
UA/ml
0.996 0.966-1.027 0.801
Cat-specifi c IgE titers, UA/ml 0.920 0.512-1.653 0.779
Dog-specifi c IgE titers, UA/ml 1.110 0.575-2.141 0.756
Inhaled corticosteroids, dose 
(×100), μg/day†
1.293 0.970-1.732 0.079
Abbreviations: CI, confi dence interval.
†Fluticasone propionate or equivalent.
Table　5　Multivariate analysis of factors associated with low 
levels of Min%Max PEF (<80%)
Characteristics AdjustedOR 95% CI p Value
Duration of asthma (×10), y 0.672 0.285-1.586 0.365
FEV1, % of predicted value 0.991 0.956-1.026 0.596
Der 1, μg/g dust 0.931 0.858-1.011 0.088
Fel d 1, μg/g dust 0.968 0.896-1.046 0.413
Can f 1, μg/g dust 0.997 0.992-1.002 0.174
Exposure scores 15.850 1.369-183.563 0.027
Dust mite-specifi c IgE titers, 
UA/ml
1.001 0.998-1.005 0.344
Cat-specifi c IgE titers, UA/ml 0.985 0.937-1.036 0.565
Dog-specifi c IgE titers,  UA/ml 0.868 0.686-1.099 0.241
Sensitization scores 0.498 0.030-8.257 0.626
Inhaled corticosteroids, dose 
(×100), μg/day†
1.429 1.013-2.017 0.042
Abbreviations: CI, confi dence interval.
†Fluticasone propionate or equivalent.
multivariate models for Min%Max PEF differed from
the univariate models in that exposure scores and the
inhaled corticosteroid dose were significantly associ-
ated, while other variables were not (Table 5).
DISCUSSION
Bedding is the most important source of mite aller-
gens in indoor environments and exposure to mite al-
lergens in daily life occurs predominantly while sleep-
ing at night.9 The Der 1 level (median, 14.9 μgg
dust) and the percentage of patients with a high level
of exposure (56%) in this study were higher than
those reported from the USA14 and Europe15 but
lower than from Australia,2 although these were gen-
eral population studies. Our hospital lies 200 km west
Indoor Allergens and Asthma Control
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of Tokyo and all patients live in a typical South East
Asian climate of high temperature and high humidity.
It is suggested that the living conditions and tradi-
tional Japanese lifestyle are associated with high dust
mite concentrations in dust samples. In contrast, the
Fel d 1 and Can f 1 levels in this study were lower
than those reported from other countries,2,4,16,17 pos-
sibly reflecting the lower frequency of pet ownership
of the patients (32%) and the communities where they
live.
The sensitization rates to dust mites, cats, and
dogs in this study were 34%, 17%, and 16%, respec-
tively, which were lower than those of 60%, 49%, and
40%, respectively, in 462 asthmatic patients reported
by Langley et al..4 Possible explanations for the differ-
ences include older age (60 versus 42 years) and fre-
quency of pet ownership (32% versus 43%).
Multivariate analyses revealed that exposure
scores, the number of highly exposed allergens, were
associated with Min%Max PEF, an asthma control
variable. Min%Max PEF is the most common method
of calculating between-day PEF variability, which in-
creases as PEF variation decreases.18 Since dust sam-
ples were collected from bedding in this study, the
exposure level to indoor allergens predominantly
means that while sleeping at night. In view of the lack
of association between Min%Max PEF and FEV1 in
the multivariate model, variation in lung function ap-
pears to represent a different aspect of asthma con-
trol from static lung functions and is suitable for as-
sessing the association with exposure levels. The im-
portance of reducing allergen exposure in asthma
care was suggested in this study.
There was no association between each allergen
concentration and Min%Max PEF or ACT scores, in-
dicating that the effect of indoor allergens on asthma
control should be assessed not as single allergens but
as multiple allergens. Few studies have examined the
role of multiple allergen exposure in relation to
asthma. The National Survey of Lead and Allergens
in Housing in the USA reported that a high multiple
allergen burden increased the odds of having asthma
symptoms (OR = 1.81),6 but the effect on lung func-
tion was not studied. Langley et al. reported that asth-
matic patients both sensitized and exposed to high
levels of sensitizing allergen had lower FEV1, higher
exhaled nitric oxide, and more severe airway reactiv-
ity than patients not sensitized and exposed.4 Unfor-
tunately, we found no association between the
sensitization-related variables and Min%Max PEF or
ACT scores, suggesting that exposure rather than
sensitization to indoor allergens may affect the
asthma control level.
The FEV1 was associated with a low ACT level but
variables concerning allergen exposure were not.
The low but significant correlation between ACT
scores and FEV1 values has been reported previ-
ously.11 This finding suggests that the ACT, a vali-
dated questionnaire for asthma control, is not suit-
able for the assessment of allergen exposure effects
and that ACT may reflect the different aspects of
asthma control from Min%Max PEF.
Since this study was a small cross-sectional one, it
is difficult to assess the cause-and-effect relationship
between exposure and sensitization to indoor aller-
gens in the studied population. There are conflicting
reports in this regard. Custovic et al. investigated the
relationship between current exposure to dust mite,
cat, and dog allergens with sensitization to inhalant
allergens using a dust sampling and skin prick tests
in a large sample of 2502 adults.19 They found that
sensitization to dust mites increased with the increas-
ing exposure, whereas cat ownership was associated
with a lower prevalence of sensitization to cat and
dog. Dharmage et al. also assessed the influence of
current indoor levels of house dust mite allergen and
cat allergen on sensitization in a follow up study with
485 adults.2 They found that people exposed to high
Der p 1 levels in dust were less likely to be sensitized
to house dust mites and high Fel d 1 levels were
found to increase the risk of being sensitized to cats.
These findings suggest that depending on the stud-
ied population, the study design, and statistical meth-
ods, results may be changeable. A large scale, longi-
tudinal study will be at least partly required to assess
the cause-and-effect relationship between exposure
and sensitization to indoor allergens.
Recently, there are some reports in support of the
hygiene hypothesis.20 Campo et al. assessed the rela-
tionships between early pet ownership and endotoxin
exposure with atopy and wheezing during infancy.
They found that high endotoxin exposure in the pres-
ence of multiple dogs were associated with reduced
wheezing.21 This hypothesis is attractive, but there
are difficulties in accepting it since preventive effect
of pet-keeping on atopy or asthma has not been
proven. The present study does not negate the hy-
giene hypothesis but does not recommend pet-
keeping for patients with asthma, either.
Although the limitations of this study include a
small sample size, a study population of old age, and a
high percentage of controlled patients, we believe
that we have demonstrated the importance of reduc-
ing allergen exposure in clinical practice.
In conclusion, this study shows that exposure, but
not sensitization, to multiple indoor allergens, includ-
ing house dust mites, cats, and dogs, is associated
with the asthma control level determined by PEF
variation. We should keep in mind the importance of
indoor allergen exposure as well as pharmacotherapy
in asthma care.
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